Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04696159 · ClinicalTrials.gov registry record · NA
Impact of Per Oral Pyloromyotomy (POP) on Glycemic Control in Diabetes
A NA study of Diabetes Mellitus and Gastroparesis, sponsored by Matthew Allemang.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT04696159: Recruiting NA study of Diabetes Mellitus and Gastroparesis, sponsored by Matthew Allemang.
NCT04696159 is a NA study of Diabetes Mellitus and Gastroparesis that is actively recruiting participants, run by Matthew Allemang. The registered enrollment target is 40 participants, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04696159, a NA study of Diabetes Mellitus and Gastroparesis, is actively recruiting participants, sponsored by Matthew Allemang.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will assess changes in glycemic control in 40 patients with diabetes who undergo per-oral pyloromyotomy (POP) for medically refractory gastroparesis.
Primary Outcome
Glycemic control will be evaluated by measuring change in Hemoglobin A1C (HbA1c) levels. Poor glycemic control defined as an average HbA1c \> 7.5%. Change = (Six Month Score - Baseline Score)
Conditions Studied
Interventions
- PROCEDURE Pyloromyotomy
Study Locations (1)
Ohio
- Cleveland Clinic Foundation - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-01-04 |
| Est. Completion | 2027-06 |
| Phase | NA |
What NCT04696159 shows while recruiting
NCT04696159 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (98% lower).
The record links to 3 conditions, with Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which Pyloromyotomy is the first listed.
NCT04696159 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT04696159 about?
NCT04696159 is a clinical study titled "Impact of Per Oral Pyloromyotomy (POP) on Glycemic Control in Diabetes". This study will assess changes in glycemic control in 40 patients with diabetes who undergo per-oral pyloromyotomy (POP) for medically refractory gastroparesis.
What is the current status of trial NCT04696159?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2023-01-04. Estimated completion is 2027-06.
What conditions does trial NCT04696159 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Gastroparesis, Gastroparesis With Diabetes Mellitus.
What interventions are being tested in trial NCT04696159?
The interventions under investigation include: Pyloromyotomy (PROCEDURE).
Who is sponsoring clinical trial NCT04696159?
This trial is sponsored by Matthew Allemang, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04696159 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04696159's enrollment target sits among peer trials
40 162nd of 208 higher than 42 of 208 other Diabetes Mellitus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Glycemic Control With Telemedicine and Smart Insulin Pens
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility
RECRUITING · NA
-
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
RECRUITING · NA
-
Innovative Multi-Variable Biofeedback for Improving Gait Performance in Individuals With Diabetic Peripheral Neuropathy
RECRUITING · NA
-
Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI